In the last 12 months, insiders at INTERPACE BIOSCIENCES, INC. ($IDXG) filed 15 transactions with the SEC: 0 open-market purchases totaling $0 and 0 sales totaling $0. Net insider sentiment: neutral.
INTERPACE BIOSCIENCES, INC. operates in the Surgical & medical instruments & apparatus industry (Industrial Applications and Services sector).
Most Active Insiders
- Ampersand 2018 Limited Partnership (TenPercentOwner) — 4 transactions totaling $28,000,000
- 1315 Capital II, L.P. (TenPercentOwner) — 4 transactions totaling $19,000,001
- McCarthy Christopher (Chief Financial Officer) — 7 transactions totaling $0
View all SEC Filings for INTERPACE BIOSCIENCES, INC. (IDXG).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 20, 2026 | 1315 Capital II, L.P. | TenPercentOwner | C | Series C Convertible Preferred Stock | 19000 | $0.00 | 0.0000 | 27,695,000 | 100.00% | 0.07% |
| Jan. 20, 2026 | 1315 Capital II, L.P. | TenPercentOwner | C | Common Stock | 9405941 | $2.02 | 9,405,941.0000 | 27,695,000 | 9999.99% | 33.96% |
| Jan. 20, 2026 | Ampersand 2018 Limited Partnership | TenPercentOwner | C | Series C Convertible Preferred Stock | 28000 | $0.00 | 0.0000 | 27,695,000 | 100.00% | 0.10% |
| Jan. 20, 2026 | Ampersand 2018 Limited Partnership | TenPercentOwner | C | Common Stock | 13861386 | $2.02 | 13,861,386.0000 | 27,695,000 | 9999.99% | 50.05% |
| July 27, 2024 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 15112 | $0.00 | 45,680.0000 | 4,401,000 | 49.44% | 0.34% |
| Dec. 1, 2024 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 1111 | $0.00 | 46,791.0000 | 4,423,000 | 2.43% | 0.03% |
| July 31, 2023 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 7556 | $0.00 | 15,872.0000 | 4,316,000 | 90.86% | 0.18% |
| Dec. 1, 2023 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 1095 | $0.00 | 16,967.0000 | 4,355,000 | 6.90% | 0.03% |
| Jan. 31, 2024 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 7556 | $0.00 | 24,523.0000 | 4,364,000 | 44.53% | 0.17% |
| Feb. 1, 2024 | McCarthy Christopher | Chief Financial Officer | M | Common Stock | 6045 | $0.00 | 30,568.0000 | 4,364,000 | 24.65% | 0.14% |
| Oct. 11, 2024 | Ampersand 2018 Limited Partnership | TenPercentOwner | A | Series C Convertible Preferred Stock | 28000 | $0.00 | 28,000.0000 | 4,423,000 | 9999.99% | 0.63% |
| Oct. 11, 2024 | Ampersand 2018 Limited Partnership | TenPercentOwner | D | Series B Convertible Preferred Stock | 28000 | $0.00 | 0.0000 | 4,423,000 | 0.00% | 0.63% |
| Oct. 11, 2024 | 1315 Capital II, L.P. | TenPercentOwner | A | Series C Convertible Preferred Stock | 19000 | $0.00 | 19,000.0000 | 4,423,000 | 9999.99% | 0.43% |
| Oct. 11, 2024 | 1315 Capital II, L.P. | TenPercentOwner | D | Series B Convertible Preferred Stock | 19000 | $0.00 | 0.0000 | 4,423,000 | 0.00% | 0.43% |
| Feb. 1, 2024 | McCarthy Christopher | Chief Financial Officer | A | Common Stock | 10000 | $0.00 | 45,644.0000 | 4,364,000 | 28.06% | 0.23% |